Immuto Scientific

About Immuto Scientific

Immuto Scientific is a company focused on tackling cancer through a unique approach of analyzing surface protein structures in their native disease context to pinpoint highly specific targets for novel therapeutics. They aim to uncover a universe of novel targets and enable precision therapeutics.

Products & Services

AI-Enabled Structural Surfaceome Platform:A patented, high-throughput platform for characterizing the structural surfaceome of diseases to identify novel epitopes for targeted therapeutics.

Native-State Structural Proteomics:Leverages unique protein conformations across surface-expressed proteins to enable precision therapeutics.

Ultrasensitive Mass Spectrometry:Integrates bottom-up proteomics with structural data at scale to identify disease-specific protein conformers.

AI/ML Capabilities:Incorporates machine learning-driven sequence design, conformational modeling, and predictive analytics to enhance target selection and drug candidate engineering.

Specialties

Surface Protein Conformations (SPCs) Structural Surfaceome Analysis AI and Machine Learning in Drug Discovery Precision Therapeutics Targeted Medicine

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed 2 T: - FT: Seed 2	A: 8000000 MR: - FA: $8 million FAN: 8000000	D: 2025-09-18 FD: 2025-09-18	4 investors

Seed 2 Latest

2025-09-18

$8.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

F

Faraz A Choudhury

CEO & Founder

D

Daniel Benjamin

Co-Founder & CTO

H

Hetal Marble

Chief Business Officer

N

Neal Goodwin

CSO

G

Gavin Thurston

Former SVP of Oncology Regeneron

M

Martin Carroll

Professor of Medicine (Hematology-Oncology)

View 4 more team members with Pro

Unlock Full Team Directory

Recent News